Synthesis and in vitro antitumor activity of an isomer of the marine pyridoacridine alkaloid ascididemin and related compounds

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 20, 2003, Pages 4351-4356

  Delfourne, Evelyne ^a   Kiss, Robert ^b   Le Corre, Laurent ^a   Merza, Joumaa ^a   Bastide, Jean ^a   Frydman, Armand ^c   Darro, Francis ^c,d  

^a UNIVERSITÉ DE PERPIGNAN   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Cephalon France   (France)

^d Unibioscreen SA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIMETHOXYACRIDINE; 9H QUINO[4,3,2 DE][1,7]PHENANTHROLIN 9 ONE; ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; ASCIDIDEMIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOMER; LUNG CARCINOMA; MALE; PROSTATE CARCINOMA;

EID: 0041333100     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00483-8     Document Type: Article

References (17)

1. (a) Molinski T. F. Chem. Rev. 93:1993;1825.
2. (b) Ding Q., Chichak K., Lown J. W. Curr. Med. Chem. 6:1999;1.
3. (c) Delfourne E., Bastide J. Med. Res. Rev. 23:2003;234.
4. Kobayashi J., Cheng J. F., Nakamura H., Ohizumi Y., Hirata Y., Sasaki T., Ohta T., Nozoa S. Tetrahedron Lett. 29:1988;1177.
5. (a) Matsumoto S. S., Sidford M. H., Holden J. A., Barrows L. R., Copp B. R. Tetrahedron Lett. 41:2000;1667.
6. (b) Lindsay B. S., Christiansen H. C., Copp B. R. Tetrahedron. 56:2000;497.
7. Cuerva J. M., Cardenas D. J., Echavarren A. M. Chem. Commun. 1999;1721.
8. Alvarez M., Feliu L., Ajana W., Joule J. A., Fernandez-Puentes J. L. Eur. J. Chem. 2000;849.
9. Cuerva J. M., Cardenas D. J., Echavarren A. M. J. Chem. Soc., Perkin Trans. 1. 11:2002;1360.
10. (a) Delfourne E., Darro F., Bontemps-Subielos N., Decaestecker C., Bastide J., Frydman A., Kiss R. J. Med. Chem. 44:2001;3275.
11. (b) Delfourne E., Darro F., Portefaix P., Galaup C., Bayssade S., Bouteille A., Le Corre L., Bastide J., Collignon F., Lesur B., Frydman A., Kiss R. J. Med. Chem. 45:2002;3765.
12. Ionescu M., Mester I. Rev. Roum. Chim. 14:1969;789.
13. Bracher F. Heterocycles. 29:1989;2093.
14. Weinstein J. N., Kohn K. W., Grever M. R., Viswanadhan V. N., Rubinstein L. V., Monks A. P., Scudiero D. A., Welch L., Koutsoukos A. D., Chiausa A. J., Paull K. D. Science. 258:1992;447.
15. Mean graphs depicting the dose-response data for compounds submitted to the NCI can be viewed, by searching for the NSC number of the compound at the NCI web site: http://dtp.nci.nih.gov/docs/cancer/searches/cancer_open_compounds.html .
16. Pauwels O., Kiss R., Pasteels J. L., Atassi G. Pharm. Res. 12:1995;1011.
17. Camby I., Salmon I., Danguy A., Pasteels J. L., Brotchi J., Martinez J., Kiss R. J. Natl. Cancer Inst. 88:1996;594.